SBC SBC Medical Group Holdings Inc
Services-Offices & Clinics of Doctors of Medicine · Nasdaq · SEC CIK 1930313 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.7%
TTM net income YoY19.8%
TTM EPS YoY21.4%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—
Margins
Gross margin72.2%
Operating margin39.9%
Net margin27.3%
FCF margin52.6%
EBITDA margin41.1%
Returns
ROE19.4%
ROA13.9%
ROIC (approx.)37.5%
Asset turnover0.51x
Leverage & solvency
Liabilities / assets28.6%
Debt / equity0.12x
Current ratio3.67x
Interest coverage181.93x
Cash quality & payout
Operating cash flow / net income1.97x
Accruals ratio-13.5%
Payout ratio—
Capex / revenue1.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $58.58M | $49.19M | $43.06M | $39.57M | $43.35M | $43.36M | $47.33M | $44.42M |
| Cost of revenue | $16.40M | $13.21M | $12.71M | $10.64M | $12.74M | $13.35M | $9.60M | $10.55M |
| Gross profit | $42.18M | $35.98M | $30.35M | $28.93M | $30.61M | $30.01M | $37.73M | $33.87M |
| SG&A expense | $15.76M | $17.02M | $12.63M | $16.08M | $14.73M | $15.46M | $13.53M | $13.88M |
| Operating income | $26.42M | $18.96M | $17.72M | $12.85M | $15.88M | $14.55M | $24.20M | $4.72M |
| Interest expense | $126,740 | $126,108 | $111,860 | $52,752 | $44,851 | $46,674 | $3,961 | $12,402 |
| Pretax income | $26.38M | $19.55M | $18.86M | $18.57M | $18.51M | $13.54M | $31.45M | $6.06M |
| Income tax | $9.38M | $7.82M | $7.53M | $4.29M | $5.67M | $11.10M | $9.96M | -$488,553 |
| Net income | $15.69M | $10.69M | $11.31M | $14.20M | $12.82M | $2.46M | $21.50M | $6.54M |
| EBITDA | $26.91M | $19.40M | $18.39M | $13.52M | $16.33M | $15.12M | $24.83M | $5.65M |
| EPS (basic) | 0.15 | 0.10 | 0.11 | — | 0.12 | 0.02 | 0.21 | — |
| EPS (diluted) | 0.15 | 0.10 | 0.11 | — | 0.12 | 0.02 | 0.21 | — |
| Weighted avg. shares (diluted) | 102.58M | 102.58M | 102.58M | — | 102.64M | 103.51M | 103.28M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $198.43M | $184.31M | $167.31M | $163.77M | $127.43M | $152.74M | $132.06M | $125.04M |
| Short-term investments | $318,297 | $307,922 | $313,865 | $319,193 | — | — | — | $0 |
| Inventory | $2.95M | $2.98M | $2.32M | $2.79M | $1.68M | $1.71M | $1.69M | $1.49M |
| Current assets | $273.86M | $259.39M | $238.78M | $231.22M | $227.20M | $241.34M | $215.10M | $184.45M |
| PP&E, net | $8.53M | $7.41M | $7.29M | $7.54M | $7.00M | $8.06M | $8.52M | $8.77M |
| Goodwill | $15.08M | $15.18M | $15.40M | $15.43M | $4.92M | $5.01M | $4.78M | $4.61M |
| Intangibles | $45.23M | $45.69M | $47.15M | $47.74M | $47.74M | $1.58M | $1.54M | $1.59M |
| Total assets | $424.82M | $406.66M | $388.02M | $380.45M | $321.36M | $315.30M | $284.61M | $266.08M |
| Current liabilities | $74.67M | $78.46M | $62.57M | $61.12M | $44.58M | $60.68M | $48.47M | $61.19M |
| Short-term debt | $201,722 | $203,512 | $219,601 | $228,210 | $250,489 | $266,573 | $266,011 | $262,095 |
| Long-term debt | $33.60M | $37.75M | $40.44M | $42.83M | $21.12M | $7.10M | $6.86M | $6.60M |
| Total debt | $33.80M | $37.96M | $40.65M | $43.06M | $21.37M | $7.37M | $7.13M | $6.86M |
| Total liabilities | $121.35M | $126.74M | $117.64M | $117.14M | $73.30M | $70.65M | $58.28M | $71.06M |
| Shareholders' equity | $286.85M | $263.84M | $255.34M | $248.28M | $247.99M | $244.59M | $226.45M | $195.11M |
| Net debt | -$164.62M | -$146.35M | -$126.65M | -$120.71M | -$106.06M | -$145.37M | -$124.92M | -$118.18M |
| Shares outstanding | 102.58M | 102.58M | 102.58M | 102.58M | 102.58M | 103.10M | 103.61M | 102.75M |
| Cash flow statement | ||||||||
| Operating cash flow | $18.51M | $22.51M | $9.23M | $51.96M | -$20.88M | -$8.34M | $1.93M | -$7.30M |
| Capital expenditure | $1.01M | $84,396 | $124,995 | $797,528 | $43,053 | $306,706 | $253,725 | $590,358 |
| Free cash flow | $17.50M | $22.42M | $9.11M | $51.17M | -$20.93M | -$8.65M | $1.67M | -$7.89M |
| Investing cash flow | -$5.08M | $565,231 | -$528,025 | -$24.21M | -$12.16M | $16.38M | -$978,807 | -$4.55M |
| Financing cash flow | -$5.14M | -$1.96M | -$1.84M | $19.82M | $11.57M | $7.18M | -$280,380 | $11.38M |
| Depreciation & amortization | $497,339 | $441,392 | $670,434 | $673,684 | $452,969 | $564,158 | $628,304 | $931,596 |
| Stock-based compensation | $11,687 | — | — | $0 | $0 | — | — | $215,237 |
| Share buybacks | $0 | — | — | $0 | $2.58M | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 17 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.